{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:39:23Z","timestamp":1793263163124,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,8,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer is the most common cancer among women, with improved survival rates due to advances in early diagnosis and therapies. However, long-term survivors (\u22655 years post-treatment, disease-free) face persistent physical, psychological, and social challenges requiring tailored, evidence-based care. Despite the growing survivor population, no systematic evaluation of Clinical Practice Guidelines (CPGs) for this group has been conducted. This study assesses the quality of CPGs and their evidence-based recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted in PubMed, CINAHL, and Cochrane Library (2015\u20132023), including guidelines from major oncology organisations. The AGREE II instrument evaluated CPG quality across six domains, and recommendations were classified using a Primary Care survivorship framework: prevention, surveillance, care coordination, and long-term effect management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten CPGs met inclusion criteria, with 7 classified as high quality. Most recommendations focused on prevention (adjuvant therapy, alcohol) and surveillance (follow-up, mammography), while gaps remained in lifestyle guidance, psychosocial support, and management of complications (lymphedema, osteoporosis, cognitive dysfunction). Care coordination and psychosocial interventions were inconsistently addressed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Current CPGs inadequately cover the complex needs of long-term survivors, particularly in psychosocial care. Evidence-based, patient-centred guidelines are urgently needed to optimise long-term outcomes and quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-025-03059-5","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T06:40:31Z","timestamp":1747464031000},"page":"178-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Systematic review of clinical practice guidelines for long-term breast cancer survivorship: assessment of quality and evidence-based recommendations"],"prefix":"10.1038","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1395-7285","authenticated-orcid":false,"given":"Gustavo Adolfo","family":"Pimentel-Parra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6022-559X","authenticated-orcid":false,"given":"Cristina","family":"Garc\u00eda-Vivar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Escalada-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"San Mart\u00edn-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelia","family":"Soto-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"3059_CR1","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. Available from: https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"key":"3059_CR2","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"O Abe","year":"2005","unstructured":"Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087\u2013106.","journal-title":"Lancet"},{"key":"3059_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1470-2045(03)01037-4","volume":"4","author":"I Jatoi","year":"2003","unstructured":"Jatoi I, Miller AB. Why is breast-cancer mortality declining? Lancet Oncol. 2003;4:251\u20134.","journal-title":"Lancet Oncol"},{"key":"3059_CR4","unstructured":"Wild C, Weiderpass E, Stewart B. World cancer report: cancer research for cancer prevention. Vol. 199, Cancer control. Lyon, France: International Agency for Research on Cancer; 2020. p. 613. Available from: http:\/\/publications.iarc.fr\/586."},{"key":"3059_CR5","unstructured":"American Cancer Society (ACS). Global cancer facts & figures. 5th ed. Atlanta, USA: American Cancer Society; 2024. p. 48."},{"key":"3059_CR6","unstructured":"American Cancer Society (ACS). Breast cancer facts & figures 2024-2025. Atlanta, USA: American Cancer Society; 2024. p. 28."},{"key":"3059_CR7","unstructured":"Australian Institute of Health and Welfare. Cancer data in Australia. 2024. p. 248. Available from: https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-data-in-australia\/contents\/overview."},{"key":"3059_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1470-2045(23)00646-0","volume":"25","author":"R De Angelis","year":"2024","unstructured":"De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, et al. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. Lancet Oncol. 2024;25:293\u2013307. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204523006460.","journal-title":"Lancet Oncol"},{"key":"3059_CR9","first-page":"409","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72:409\u201336. Available from: https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.3322\/caac.21731.","journal-title":"CA Cancer J Clin"},{"key":"3059_CR10","unstructured":"Institute of Medicine (IOM), National Research Council (NRC). In: Hewitt M, Greenfield S, Stovall E, editors. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2006. p. 534."},{"key":"3059_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/PPO.0b013e31818edf60","volume":"14","author":"K Miller","year":"2008","unstructured":"Miller K, Merry B, Miller J. Seasons of survivorship revisited. Cancer J. 2008;14:369\u201374.","journal-title":"Cancer J"},{"key":"3059_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1056\/NEJM198507253130421","volume":"313","author":"F Mullan","year":"1985","unstructured":"Mullan F. Seasons of survival: reflections of a physician with cancer. N Engl J Med. 1985;313:270\u20131.","journal-title":"N Engl J Med"},{"key":"3059_CR13","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1200\/JCO.22.00174","volume":"40","author":"ER Brauer","year":"2022","unstructured":"Brauer ER, Ganz PA. Moving the translational needle in breast cancer survivorship: connecting intervention research to clinical practice. J Clin Oncol. 2022;40:2069\u201373. Available from: https:\/\/ascopubs.org\/doi\/10.1200\/JCO.22.00174.","journal-title":"J Clin Oncol"},{"key":"3059_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/s12885-023-11087-8","volume":"23","author":"R Fan","year":"2023","unstructured":"Fan R, Wang L, Bu X, Wang W, Zhu J. Unmet supportive care needs of breast cancer survivors: a systematic scoping review. BMC Cancer. 2023;23:587. Available from: https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-023-11087-8.","journal-title":"BMC Cancer"},{"key":"3059_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/spcare-2022-003931","volume":"13","author":"R Khajoei","year":"2023","unstructured":"Khajoei R, Ilkhani M, Azadeh P, Zohari Anboohi S, Heshmati Nabavi F. Breast cancer survivors-supportive care needs: systematic review. BMJ Support Palliat Care. 2023;13:143\u201353. Available from: https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2022-003931.","journal-title":"BMJ Support Palliat Care"},{"key":"3059_CR16","first-page":"43","volume":"66","author":"CD Runowicz","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016;66:43\u201373.","journal-title":"CA Cancer J Clin"},{"key":"3059_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/NCC.0000000000001167","volume":"45","author":"C Garc\u00eda-Vivar","year":"2022","unstructured":"Garc\u00eda-Vivar C. The use and misuse of the concept of cancer survivor. Cancer Nurs. 2022;45:419\u201320. Available from: https:\/\/journals.lww.com\/10.1097\/NCC.0000000000001167.","journal-title":"Cancer Nurs"},{"key":"3059_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1200\/JCO.2017.73.7932","volume":"36","author":"A Jemal","year":"2018","unstructured":"Jemal A, Robbins AS, Lin CC, Flanders WD, DeSantis CE, Ward EM, et al. Factors that contributed to black-white disparities in survival among nonelderly women with breast cancer between 2004 and 2013. J Clin Oncol. 2018;36:14\u201324. Available from: https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2017.73.7932.","journal-title":"J Clin Oncol"},{"key":"3059_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1200\/JCO.2017.74.2049","volume":"36","author":"L Ellis","year":"2018","unstructured":"Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R, Gomez SL. Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics. J Clin Oncol. 2018;36:25\u201333. Available from: https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2017.74.2049.","journal-title":"J Clin Oncol"},{"key":"3059_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10549-021-06311-7","volume":"190","author":"NC Lorona","year":"2021","unstructured":"Lorona NC, Malone KE, Li CI. Racial\/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis. Breast Cancer Res Treat. 2021;190:549\u201358. Available from: https:\/\/link.springer.com\/10.1007\/s10549-021-06311-7.","journal-title":"Breast Cancer Res Treat"},{"key":"3059_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1055\/a-2238-3199","volume":"84","author":"PA Fasching","year":"2024","unstructured":"Fasching PA, Kreipe H, Del Mastro L, Ciruelos E, Freyer G, Korfel A, et al. Identification of patients with early HR+ HER2\u2212 breast cancer at high risk of recurrence. Geburtshilfe Frauenheilkd. 2024;84:164\u201384. Available from: http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2238-3199.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"3059_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.breast.2021.02.009","volume":"57","author":"EM Salvo","year":"2021","unstructured":"Salvo EM, Ramirez AO, Cueto J, Law EH, Situ A, Cameron C, et al. Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: a systematic review and meta-analysis. Breast. 2021;57:5\u201317. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977621000230.","journal-title":"Breast"},{"key":"3059_CR23","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1503\/cmaj.090449","volume":"182","author":"MC Brouwers","year":"2010","unstructured":"Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J. 2010;182:839\u201342.","journal-title":"Can Med Assoc J"},{"key":"3059_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4067\/S0034-98872014000100016","volume":"142","author":"B Pe\u00f1aloza","year":"2014","unstructured":"Pe\u00f1aloza B. An\u00e1lisis cr\u00edtico de un art\u00edculo: An\u00e1lisis de una revisi\u00f3n sistem\u00e1tica sobre calidad de gu\u00edas de pr\u00e1ctica cl\u00ednica. Rev Med Chile. 2014;142:105\u20138. Available from: http:\/\/www.scielo.cl\/scielo.php?script=sci_arttext&pid=S0034-98872014000100016&lng=en&nrm=iso&tlng=en.","journal-title":"Rev Med Chile"},{"key":"3059_CR25","doi-asserted-by":"crossref","unstructured":"Bierbaum M, Rapport F, Arnolda G, Delaney GP, Liauw W, Olver I, et al. Clinical practice guideline adherence in oncology: a qualitative study of insights from clinicians in Australia. PLoS ONE. 2022;17:e0279116. Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0279116.","DOI":"10.1371\/journal.pone.0279116"},{"key":"3059_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12913-023-09189-x","volume":"23","author":"A-M Bora","year":"2023","unstructured":"Bora A-M, Piechotta V, Kreuzberger N, Monsef I, Wender A, Follmann M, et al. The effectiveness of clinical guideline implementation strategies in oncology\u2014a systematic review. BMC Health Serv Res. 2023;23:347. Available from: https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-09189-x.","journal-title":"BMC Health Serv Res"},{"key":"3059_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0140-6736(99)02171-6","volume":"355","author":"R Grilli","year":"2000","unstructured":"Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet. 2000;355:103\u20136. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673699021716.","journal-title":"Lancet"},{"key":"3059_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2018.11.030","volume":"108","author":"A Johnston","year":"2019","unstructured":"Johnston A, Kelly SE, Hsieh SC, Skidmore B, Wells GA. Systematic reviews of clinical practice guidelines: a methodological guide. J Clin Epidemiol. 2019;108:64\u201376. https:\/\/doi.org\/10.1016\/j.jclinepi.2018.11.030.","journal-title":"J Clin Epidemiol"},{"key":"3059_CR29","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","volume":"74","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. Declaraci\u00f3n PRISMA 2020: una gu\u00eda actualizada para la publicaci\u00f3n de revisiones sistem\u00e1ticas. Rev Espa\u00f1ola Cardiol. 2021;74:790\u20139.","journal-title":"Rev Espa\u00f1ola Cardiol"},{"key":"3059_CR30","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Antes G, Atkins D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"3059_CR31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1177\/0194599815573735","volume":"153","author":"RK Gurgel","year":"2015","unstructured":"Gurgel RK. Updating clinical practice guidelines: How do we stay current? Otolaryngol Head Neck Surg. 2015;153:488\u201390.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"3059_CR32","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/hex.13753","volume":"26","author":"M Rivera-Izquierdo","year":"2023","unstructured":"Rivera-Izquierdo M, Maes-Carballo M, Jim\u00e9nez-Mole\u00f3n JJ, Mart\u00ednez-Ruiz V, Blaak\u00e6r J, Olmedo-Requena R, et al. Gender bias in shared decision-making among cancer care guidelines: a systematic review. Heal Expect. 2023;26:1019\u201338.","journal-title":"Heal Expect"},{"key":"3059_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/BF02600272","volume":"11","author":"RSA Hayward","year":"1996","unstructured":"Hayward RSA, Wilson MC, Tunis SR, Guyatt GH, Moore K, Bass EB. Practice guidelines: What are internists looking for? J Gen Intern Med. 1996;11:176\u20138.","journal-title":"J Gen Intern Med"},{"key":"3059_CR34","unstructured":"Veritas Health Innovation. Covidence systematic review software. Melbourne, Australia; 2024. Available from: www.covidence.org."},{"key":"3059_CR35","unstructured":"Consorcio AGREE. Instrumento para la evaluaci\u00f3n de gu\u00edas de pr\u00e1ctica cl\u00ednica AGREE II. AGREE Research Trust; 2009. p. 57. Available from: http:\/\/www.guiasalud.es\/contenidos\/documentos\/Guias_Practica_Clinica\/Spanish-AGREE-II.pdf."},{"key":"3059_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.pmn.2022.02.010","volume":"23","author":"NV Suresh","year":"2022","unstructured":"Suresh NV, Harris J, Chorath K, Rizvi A, Rizvi F, Acosta P, et al. Clinical practice guidelines in the management of breakthrough cancer pain: a systematic review using the Appraisal of Guidelines for Research and Evaluation (AGREE II) Instrument. Pain Manag Nurs. 2022;23:411\u20137. https:\/\/doi.org\/10.1016\/j.pmn.2022.02.010.","journal-title":"Pain Manag Nurs"},{"key":"3059_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/cam4.1933","volume":"8","author":"V Romeo","year":"2019","unstructured":"Romeo V, Stanzione A, Cocozza S, Ugga L, Cuocolo R, Brunetti A, et al. A critical appraisal of the quality of head and neck cancer imaging guidelines using the AGREE II tool: a EuroAIM initiative. Cancer Med. 2019;8:209\u201315.","journal-title":"Cancer Med"},{"key":"3059_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/fampra\/cmu082","volume":"32","author":"M Luctkar-Flude","year":"2015","unstructured":"Luctkar-Flude M, Aiken A, McColl MA, Tranmera J. A comprehensive framework and key guideline recommendations for the provision of evidence based breast cancer survivorship care within the primary care setting. Fam Pract. 2015;32:129\u201340.","journal-title":"Fam Pract"},{"key":"3059_CR39","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1158\/1055-9965.EPI-11-0622","volume":"20","author":"E Grunfeld","year":"2011","unstructured":"Grunfeld E, Earle CC, Stovall E. A framework for cancer survivorship research and translation to policy. Cancer Epidemiol Biomarkers Prev. 2011;20:2099\u2013104.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3059_CR40","first-page":"101","volume":"62","author":"T Salz","year":"2012","unstructured":"Salz T, Oeffinger KC, McCabe MS, Layne TM, Bach PB. Survivorship care plans in research and practice. CA Cancer J Clin. 2012;62:101\u201317.","journal-title":"CA Cancer J Clin"},{"key":"3059_CR41","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1200\/JCO.2008.20.4883","volume":"27","author":"ME Del Giudice","year":"2009","unstructured":"Del Giudice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S. Primary care physicians\u2019 views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27:3338\u201345. Available from: https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2008.20.4883.","journal-title":"J Clin Oncol"},{"key":"3059_CR42","doi-asserted-by":"crossref","unstructured":"Grunfeld E, Earle CC. The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr. 2010;2010:25\u201330. [cited 2024 Oct 14]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3482947\/","DOI":"10.1093\/jncimonographs\/lgq002"},{"key":"3059_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1200\/JCO.18.01160","volume":"37","author":"HJ Burstein","year":"2018","unstructured":"Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KA, et al. Adjuvant endocrine therapy for women with hormone receptor\u2013positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol. 2018;37:423\u201338.","journal-title":"J Clin Oncol"},{"key":"3059_CR44","unstructured":"Biganzoli L, Calabrese M, Conte B, Cortesi L, Criscitiello C, Del Mastro L, et al. Breast neoplasms guidelines. Italy: Associazione Italiana di Oncologia Medica (AIOM); 2018. p. 263. Available from: https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/11\/2018_LG_AIOM_Breast_ENversion.pdf."},{"key":"3059_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/03008916221088885","volume":"108","author":"A Ciabattoni","year":"2022","unstructured":"Ciabattoni A, Gregucci F, De Rose F, Falivene S, Fozza A, Daidone A, et al. AIRO Breast Cancer Group Best Clinical Practice 2022 Update. Tumori J. 2022;108:1\u2013144.","journal-title":"Tumori J"},{"key":"3059_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","volume":"35","author":"S Loibl","year":"2024","unstructured":"Loibl S, Andr\u00e9 F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024;35:159\u201382.","journal-title":"Ann Oncol"},{"key":"3059_CR47","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1007\/s12094-023-03215-4","volume":"25","author":"F Ayala de la Pe\u00f1a","year":"2023","unstructured":"Ayala de la Pe\u00f1a F, Antol\u00edn Novoa S, Gavil\u00e1 Gregori J, Gonz\u00e1lez Cortijo L, Henao Carrasco F, Mart\u00ednez Mart\u00ednez MT, et al. SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022). Clin Transl Oncol. 2023;25:2647\u201364. https:\/\/doi.org\/10.1007\/s12094-023-03215-4.","journal-title":"Clin Transl Oncol"},{"key":"3059_CR48","unstructured":"Stangl S, Follmann M, Wenzel G, Langer T, W\u00f6ckel A. Evidence-based guideline for the early detection, diagnosis, treatment and follow-up of breast cancer. Germany: German Guideline Program in Oncology (GGPO); 2021. p. 462."},{"key":"3059_CR49","unstructured":"National Institute for Health and Care Excellence\u2014NICE. Early and locally advanced breast cancer: diagnosis and management. United Kingdom: National Institute for Health and Care Excellence (NICE); 2024. p. 84. Available from: www.nice.org.uk\/guidance\/ng101%0Awww.nice.org.uk\/guidance\/ng101%0Ahttps:\/\/www.nice.org.uk\/guidance\/ng101\/resources\/early-and-locally-advanced-breast-cancer-diagnosis-and-management-pdf-66141532913605."},{"key":"3059_CR50","unstructured":"Cancer Care Alberta\u2014CCA. Follow-up care for early-stage breast cancer: clinical practice guideline BR-013\u2014Version 3. Canada: Cancer Care Alberta\u2014Guideline Resource Unit (GURU); 2023. p. 15."},{"key":"3059_CR51","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.annonc.2020.01.008","volume":"31","author":"YH Park","year":"2020","unstructured":"Park YH, Senkus-Konefka E, Im SA, Pentheroudakis G, Saji S, Gupta S, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS. Ann Oncol. 2020;31:451\u201369.","journal-title":"Ann Oncol"},{"key":"3059_CR52","doi-asserted-by":"crossref","unstructured":"Le\u00f3n\u2010Salas B, \u00c1lvarez\u2010P\u00e9rez Y, Ramos\u2010Garc\u00eda V, del Mar Trujillo\u2010Mart\u00edn M, de Pascual y Medina AM, Esteva M, et al. Information needs and research priorities in long\u2010term survivorship of breast cancer: patients and health professionals\u2019 perspectives. Eur J Cancer Care. 2022;31. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ecc.13730.","DOI":"10.1111\/ecc.13730"},{"key":"3059_CR53","doi-asserted-by":"crossref","unstructured":"Vivar CG, McQueen A. Informational and emotional needs of long\u2010term survivors of breast cancer. J Adv Nurs. 2005;51:520\u20138. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2648.2005.03524.x.","DOI":"10.1111\/j.1365-2648.2005.03524.x"},{"key":"3059_CR54","unstructured":"Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica (SEOM). Plan Integral de Atenci\u00f3n a los Largos Supervivientes de C\u00e1ncer. Madrid, Espa\u00f1a: Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica (SEOM); 2013. p. 102. Available from: https:\/\/seom.org\/seomcms\/images\/stories\/recursos\/PLAN_INTEGRAL_LARGO_SUPERVIVIENTE.pdf."},{"key":"3059_CR55","doi-asserted-by":"crossref","unstructured":"Levit LA, Balogh EP, Nass SJ, Ganz PA. Delivering high-quality cancer care: charting a new course for a system in crisis. Washington, DC: Institute of Medicine of the National Academies; 2013. p. 207\u201328.","DOI":"10.17226\/18359"},{"key":"3059_CR56","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.nurpra.2021.11.007","volume":"18","author":"MA Smania","year":"2022","unstructured":"Smania MA, Corey BA, Schrader KE. Managing the breast cancer survivor in primary care. J Nurse Pract. 2022;18:140\u20136. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1555415521005146.","journal-title":"J Nurse Pract"},{"key":"3059_CR57","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1007\/s11606-016-3746-7","volume":"31","author":"RA Lawrence","year":"2016","unstructured":"Lawrence RA, McLoone JK, Wakefield CE, Cohn RJ. Primary care physicians\u2019 perspectives of their role in cancer care: a systematic review. J Gen Intern Med. 2016;31:1222\u201336. Available from: http:\/\/link.springer.com\/10.1007\/s11606-016-3746-7.","journal-title":"J Gen Intern Med"},{"key":"3059_CR58","doi-asserted-by":"publisher","first-page":"e2328328","DOI":"10.1001\/jamanetworkopen.2023.28328","volume":"6","author":"M Shi","year":"2023","unstructured":"Shi M, Luo C, Oduyale OK, Zong X, LoConte NK, Cao Y. Alcohol consumption among adults with a cancer diagnosis in the All of Us Research Program. JAMA Netw Open. 2023;6:e2328328. Available from: https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2808140.","journal-title":"JAMA Netw Open"},{"key":"3059_CR59","doi-asserted-by":"publisher","first-page":"102101","DOI":"10.1016\/j.canep.2022.102101","volume":"77","author":"J Lyu","year":"2022","unstructured":"Lyu J, Kaur M, Dibble KE, Connor AE. A national study of alcohol consumption patterns among population-based U.S. cancer survivors compared with cancer-free individuals. Cancer Epidemiol. 2022;77:102101. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782122000066.","journal-title":"Cancer Epidemiol"},{"key":"3059_CR60","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.2196\/cancer.6295","volume":"2","author":"TL Fazzino","year":"2016","unstructured":"Fazzino TL, Fleming K, Befort C. Alcohol intake among breast cancer survivors: change in alcohol use during a weight management intervention. JMIR Cancer. 2016;2:e15. Available from: http:\/\/cancer.jmir.org\/2016\/2\/e15\/.","journal-title":"JMIR Cancer"},{"key":"3059_CR61","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jdi.14043","volume":"14","author":"YK Yeh","year":"2023","unstructured":"Yeh YK, Yen F, Hwu C. Diet and exercise are a fundamental part of comprehensive care for type 2 diabetes. J Diabetes Investig. 2023;14:936\u20139. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdi.14043.","journal-title":"J Diabetes Investig"},{"key":"3059_CR62","unstructured":"Susan G. Komen. Healthy Lifestyle for Breast Cancer Survivors [Internet]. [cited 2024 Dec 5]. Available from: https:\/\/www.komen.org\/breast-cancer\/survivorship\/healthy-lifestyle\/."},{"key":"3059_CR63","unstructured":"Shaw G. After breast cancer: fitness and nutrition tips. WebMD. [cited 2024 Dec 5]. Available from: https:\/\/www.webmd.com\/breast-cancer\/features\/breast-cancer-survivors-nutrition-fitness-tips."},{"key":"3059_CR64","doi-asserted-by":"crossref","unstructured":"Morgan E, O\u2019Neill C, Bardot A, Walsh P, Woods RR, Gonsalves L, et al. Collecting long-term outcomes in population-based cancer registry data: the case of breast cancer recurrence. JCO Glob Oncol. 2024. Available from: https:\/\/ascopubs.org\/doi\/10.1200\/GO-24-00249.","DOI":"10.1200\/GO-24-00249"},{"key":"3059_CR65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12961-022-00815-4","volume":"20","author":"VC Pereira","year":"2022","unstructured":"Pereira VC, Silva SN, Carvalho VKS, Zanghelini F, Barreto JOM. Strategies for the implementation of clinical practice guidelines in public health: an overview of systematic reviews. Heal Res Policy Syst. 2022;20:13. Available from: https:\/\/health-policy-systems.biomedcentral.com\/articles\/10.1186\/s12961-022-00815-4.","journal-title":"Heal Res Policy Syst"},{"key":"3059_CR66","volume":"14","author":"A Kamata","year":"2022","unstructured":"Kamata A, Hino K, Kamiyama K, Takasaka Y. Very late recurrence in breast cancer: Is breast cancer a chronic disease? Cureus. 2022;14:e22804. https:\/\/www.cureus.com\/articles\/82333-very-late-recurrence-in-breast-cancer-is-breast-cancer-a-chronic-disease Mar 3Available from.","journal-title":"Cureus"},{"key":"3059_CR67","unstructured":"American Cancer Society. Managing cancer as a chronic illness. American Cancer Society; 2024. p. 1\u201314. Available from: https:\/\/www.cancer.org\/treatment\/survivorship-during-and-after-treatment\/when-cancer-doesnt-go-away.html."},{"key":"3059_CR68","doi-asserted-by":"crossref","unstructured":"Davies C, Levenhagen K, Ryans K, Perdomo M, Gilchrist L. Interventions for breast cancer\u2013related lymphedema: clinical practice guideline from the Academy of Oncologic Physical Therapy of APTA. Phys Ther. 2020;100:1\u201317. Available from: https:\/\/academic.oup.com\/ptj\/article-abstract\/doi\/10.1093\/ptj\/pzaa087\/5862539.","DOI":"10.1093\/ptj\/pzaa087"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03059-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03059-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03059-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:03:13Z","timestamp":1781852593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03059-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8,10]]}},"alternative-id":["3059"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03059-5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable. This systematic review used publicly available clinical practice guidelines and did not involve human participants or identifiable data; thus, ethical approval and consent were not required. All methods complied with relevant guidelines for secondary data analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript is based on a systematic review of publicly available clinical practice guidelines and does not involve any individual person\u2019s data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}